Form 4 for EYPT EyePoint, Inc.
Accepted 2024-02-13 00:00:00 ET · period of report 2024-02-09 · accession 0001562180-24-001294 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-13 | 2024-02-09 | EYPT | Lurker Nancy | Executive Vice COB, Dir | M - OptEx | $0.00 | +37.5K | 173.0K | +28% | $0 |
| D | 2024-02-13 | 2024-02-13 | EYPT | Lurker Nancy | Executive Vice COB, Dir | G - Gift | $0.00 | -74.7K | 83.4K | -47% | $0 |
| DI | 2024-02-13 | 2024-02-13 | EYPT | Lurker Nancy | Executive Vice COB, Dir | G - Gift | $0.00 | +74.7K | 126.9K | +143% | $0 |
| DM | 2024-02-13 | 2024-02-09 | EYPT | Lurker Nancy | Executive Vice COB, Dir | F - Tax | $28.80 | -14.9K | 158.0K | -9% | -$430.4K |
| DM | 2024-02-13 | 2024-02-13 | EYPT | Lurker Nancy | Executive Vice COB, Dir | G - Gift | $0.00 | -12.6K | 57.9K | -18% | $0 |
| DM | 2024-02-13 | 2024-02-09 | EYPT | Lurker Nancy | Executive Vice COB, Dir | M - OptEx | $0.00 | -37.5K | 20.0K | -65% | $0 |
| DMI | 2024-02-13 | 2024-02-13 | EYPT | Lurker Nancy | Executive Vice COB, Dir | G - Gift | $0.00 | +12.6K | 155.8K | +9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-09 | M | A | 20,000 | $0.00 | 155,441 | D By Family Trust | — | — | (F3) These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| 2 | Common | Common Stock | 2024-02-13 | G | D | 74,681 | $0.00 | 83,351 | D | — | — | |
| 3 | Common | Common Stock | 2024-02-13 | G | A | 74,681 | $0.00 | 126,889 | I | — | — | |
| 4 | Common | Common Stock | 2024-02-09 | M | A | 17,534 | $0.00 | 172,975 | D | — | — | |
| 5 | Common | Common Stock | 2024-02-09 | F | D | 7,962 | $28.80 | 165,013 | D | — | — | |
| 6 | Common | Common Stock | 2024-02-09 | F | D | 6,981 | $28.80 | 158,032 | D | — | — | |
| 7 | Derivative | Stock Option (Right to Buy) | 2024-02-13 | G | D | 3,116 | $0.00 | 1,558 | D By Family Trust | $12.90 · — to 2030-02-28 | 3,116 Common Stock | (F3) These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. (F7) The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full as of January 28, 2024. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until February 28, 2024. |
| 8 | Derivative | Stock Option (Right to Buy) | 2024-02-13 | G | D | 5,000 | $0.00 | 125,000 | D | $10.13 · — to 2032-02-09 | 5,000 Common Stock | (F9) The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full as of January 9, 2024. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until February 9, 2026. |
| 9 | Derivative | Restricted Stock Units | 2024-02-09 | M | D | 17,534 | $0.00 | 0 | D By Family Trust | $0.00 · — to 2031-02-09 | 17,534 Common Stock | (F3) These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. (F4) The restricted stock units will vest in three ratable annual installments beginning February 9, 2022. |
| 10 | Derivative | Restricted Stock Units | 2024-02-09 | M | D | 20,000 | $0.00 | 20,000 | D By Family Trust | $0.00 · — to 2032-02-09 | 20,000 Common Stock | (F3) These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. (F5) The restricted stock units will vest in three ratable annual installments beginning February 9, 2023. |
| 11 | Derivative | Stock Option (Right to Buy) | 2024-02-13 | G | A | 5,000 | $0.00 | 115,000 | I | $10.13 · — to 2032-02-09 | 5,000 Common Stock | (F9) The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full as of January 9, 2024. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until February 9, 2026. |
| 12 | Derivative | Stock Option (Right to Buy) | 2024-02-13 | G | A | 3,116 | $0.00 | 73,242 | I | $12.90 · — to 2030-02-28 | 3,116 Common Stock | (F7) The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full as of January 28, 2024. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until February 28, 2024. |
| 13 | Derivative | Stock Option (Right to Buy) | 2024-02-13 | G | D | 4,452 | $0.00 | 57,878 | D | $13.13 · — to 2031-02-09 | 4,452 Common Stock | (F8) The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full as of January 9, 2024. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until February 9, 2025. |
| 14 | Derivative | Stock Option (Right to Buy) | 2024-02-13 | G | A | 4,452 | $0.00 | 155,822 | I | $13.13 · — to 2031-02-09 | 4,452 Common Stock | (F8) The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full as of January 9, 2024. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until February 9, 2025. |